American Society of Clinical Oncology

SHERPA: White

People

  1. Scher
    Scher
  2. Eastham
    Eastham
  3. Herr
    Herr
  4. Bajorin
    Bajorin
  5. Scardino
    Scardino
  6. Carver
    Carver
  7. Danila
    Danila
  8. Lilja
    Lilja
  9. Slovin
    Slovin
  10. Heller
    Heller

Groups

  1. Department of Medicine (36)
  2. Genitourinary Oncology Service (36)
  3. Solid Tumor Oncology Division (36)
  4. Surgery (36)
  5. Urology (34)
  6. Molecular Pharmacology and Chemistry Program Faculty (13)
  7. Sloan Kettering Institute Faculty (13)
  8. GSK Faculty (11)
  9. Epidemiology and Biostatistics (9)
  10. Survivorship Research (9)
Search Within
  1. "Howard Scher"
  2. "Surgery"
Formats
  1. Meeting Abstract (24)
  2. Journal Article (12)
Groups
  1. Department of Medicine (36)
  2. Genitourinary Oncology Service (36)
  3. Solid Tumor Oncology Division (36)
  4. Surgery (36)
  5. Urology (34)
  6. Molecular Pharmacology and Chemistry Program Faculty (13)

More Groups

People
  1. Howard Scher (36)
  2. Peter Scardino (13)
  3. Harry Herr (10)
  4. James Eastham (10)
  5. Dean Bajorin (9)
  6. Fernando Bianco (8)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2015 (1)
  5. 2014 (4)
  6. 2013 (2)

More Years

Publications
  1. Journal of Clinical Oncology (36)

Results (36)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic and predictive implications of plasma ctDNA in guiding first-line targeted therapy for metastatic HER2 -mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Liu, S. Y.; Jee, J.; Santini, F. C.; Schoenfeld, A. J.; Eichholz, J.; Johnson, K.; Martinez, A.; Guo, J.; Riaz, N.; Lee, N. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Changes in Ki-67 and cleaved caspase-3 (CC3) with short term androgen deprivation therapy (ADT) prior to prostatectomy as part of a trial in intermediate and high-risk prostate cancer (PC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Chen, Y. B.; Autio, K. A.; Carver, B. S.; Slovin, S. F.; Danila, D. C.; Scher, H. I.; Touijer, K. A.; Rathkopf, D. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Metacure: Multi-arm multimodality therapy for very high risk localized and low volume metastatic prostatic adenocarcinoma
    Meeting Abstract

    Teo, M. Y.; Taplin, M. E.; Eastham, J. A.; Benoliel, H.; Kibel, A. S.; McBride, S. M.; Nguyen, P. L.; Gopalan, A.; Lis, R.; Scher, H. I.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Radical prostatectomy as a component of multimodal therapy for highly selected M1 prostate cancer patients
    Meeting Abstract

    O'Shaughnessy, M.; Eastham, J. A.; Bochner, B. H.; Laudone, V. P.; Carver, B. S.; Sjoberg, D.; Scardino, P. T.; Scher, H. I.; Touijer, K. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Establishing a neoadjuvant platform for developing targeted agents: Degarelix prior to prostatectomy for patients with intermediate- and high-risk prostate cancer
    Meeting Abstract

    Touijer, K. A.; Carver, B. S.; Coleman, J. A.; Laudone, V. P.; Hullings, M.; Ehrlich, S. S.; DeNunzio, M.; Reuter, V. E.; Eastham, J. A.; Danila, D. C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Targeting reciprocal feedback inhibition in the clinic: ARN509 and PI3K pathway inhibition in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Carver, B. S.; Chen, Y.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Autio, K. A.; DeNunzio, M.; Sawyers, C. L.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Development of novel metastatic prostate cancer cell lines by "organoid" in vitro culture technology
    Meeting Abstract

    Vela, I.; Gao, D.; Gopalan, A.; Sboner, A.; Undvall, E.; Wanjala, J.; Iaquinta, P.; Wongvipat, J.; Karthaus, W.; Clevers, H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Pelvic exenteration in patients with nonmetastatic, locally advanced castration-resistant prostate cancer
    Meeting Abstract

    Donahue, T. F.; Morris, M. J.; Hilton, W. M.; Scher, H. I.; Bochner, B. H.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Anand, A.; Danila, D. C.; Heller, G.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save